Global Recombinant Vaccines Market Research Report 2026(Status and Outlook)

May 2026 | 151 pages | ID: GC5300455DB7EN
Bosson Research

Abstracts

Recombinant vaccines are produced using recombinant DNA technology, with the help of a vector. These vaccines stimulate the immune system of an individual and provide immunity against various lethal disease. These vaccines are safe and have less or no side-effects as compared to conventional vaccines, in the prevention of various diseases such as influenza, cholera, typhoid, and dengue. Recombinant vaccines are also used in animals for prevention of diseases such as foot and mouth disease, pneumonia and septicemia, and pox disease. Vaccination results in the prevention of disease, by producing antibodies against the protein antigen of pathogenic microorganisms.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The global Recombinant Vaccines market size was estimated at USD 10080.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 11.00% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Recombinant Vaccines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Recombinant Vaccines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Recombinant Vaccines market.

Global Recombinant Vaccines Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• Merck & Co., Inc
• Green Cross Corporation
• Pfizer Inc.
• Bayer AG
• Sanofi S A.
• Protein Science Corporation
• GlaxoSmithKline Plc.
• Novartis AG
• Bharat Biotech
• AstraZeneca Plc.
• Johnson & Johnson
• Emergent BioSolutions Inc
• Novavax, Inc
• Serum Institute of India Pvt. Ltd
• Dynavax Technologies Corporation

Market Segmentation (by Type)

• Subunit Recombinant Vaccines
• Attenuated Recombinant Vaccines
• Vector Recombinant Vaccines

Market Segmentation (by Application)

• Recombinant Human Vaccines
• Animal Recombinant Vaccines

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Recombinant Vaccines Market

Overview of the regional outlook of the Recombinant Vaccines Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Recombinant Vaccines Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Recombinant Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Recombinant Vaccines
1.2 Key Market Segments
  1.2.1 Recombinant Vaccines Segment by Type
  1.2.2 Recombinant Vaccines Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 RECOMBINANT VACCINES MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Recombinant Vaccines Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Recombinant Vaccines Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 RECOMBINANT VACCINES MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Recombinant Vaccines Product Life Cycle
3.3 Global Recombinant Vaccines Sales by Manufacturers (2020-2025)
3.4 Global Recombinant Vaccines Revenue Market Share by Manufacturers (2020-2025)
3.5 Recombinant Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Recombinant Vaccines Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Recombinant Vaccines Market Competitive Situation and Trends
  3.8.1 Recombinant Vaccines Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Recombinant Vaccines Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 RECOMBINANT VACCINES INDUSTRY CHAIN ANALYSIS

4.1 Recombinant Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF RECOMBINANT VACCINES MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Recombinant Vaccines Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Recombinant Vaccines Market
5.7 ESG Ratings of Leading Companies

6 RECOMBINANT VACCINES MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Recombinant Vaccines Sales Market Share by Type (2020-2025)
6.3 Global Recombinant Vaccines Market Size by Type (2020-2025)
6.4 Global Recombinant Vaccines Price by Type (2020-2025)

7 RECOMBINANT VACCINES MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Recombinant Vaccines Market Sales by Application (2020-2025)
7.3 Global Recombinant Vaccines Market Size (M USD) by Application (2020-2025)
7.4 Global Recombinant Vaccines Sales Growth Rate by Application (2020-2025)

8 RECOMBINANT VACCINES MARKET SALES BY REGION

8.1 Global Recombinant Vaccines Sales by Region
  8.1.1 Global Recombinant Vaccines Sales by Region
  8.1.2 Global Recombinant Vaccines Sales Market Share by Region
8.2 Global Recombinant Vaccines Market Size by Region
  8.2.1 Global Recombinant Vaccines Market Size by Region
  8.2.2 Global Recombinant Vaccines Market Size by Region
8.3 North America
  8.3.1 North America Recombinant Vaccines Sales by Country
  8.3.2 North America Recombinant Vaccines Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Recombinant Vaccines Sales by Country
  8.4.2 Europe Recombinant Vaccines Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Recombinant Vaccines Sales by Region
  8.5.2 Asia Pacific Recombinant Vaccines Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Recombinant Vaccines Sales by Country
  8.6.2 South America Recombinant Vaccines Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Recombinant Vaccines Sales by Region
  8.7.2 Middle East and Africa Recombinant Vaccines Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 RECOMBINANT VACCINES MARKET PRODUCTION BY REGION

9.1 Global Production of Recombinant Vaccines by Region(2020-2025)
9.2 Global Recombinant Vaccines Revenue Market Share by Region (2020-2025)
9.3 Global Recombinant Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Recombinant Vaccines Production
  9.4.1 North America Recombinant Vaccines Production Growth Rate (2020-2025)
  9.4.2 North America Recombinant Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Recombinant Vaccines Production
  9.5.1 Europe Recombinant Vaccines Production Growth Rate (2020-2025)
  9.5.2 Europe Recombinant Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Recombinant Vaccines Production (2020-2025)
  9.6.1 Japan Recombinant Vaccines Production Growth Rate (2020-2025)
  9.6.2 Japan Recombinant Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Recombinant Vaccines Production (2020-2025)
  9.7.1 China Recombinant Vaccines Production Growth Rate (2020-2025)
  9.7.2 China Recombinant Vaccines Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Merck and Co., Inc
  10.1.1 Merck and Co., Inc Basic Information
  10.1.2 Merck and Co., Inc Recombinant Vaccines Product Overview
  10.1.3 Merck and Co., Inc Recombinant Vaccines Product Market Performance
  10.1.4 Merck and Co., Inc Business Overview
  10.1.5 Merck and Co., Inc SWOT Analysis
  10.1.6 Merck and Co., Inc Recent Developments
10.2 Green Cross Corporation
  10.2.1 Green Cross Corporation Basic Information
  10.2.2 Green Cross Corporation Recombinant Vaccines Product Overview
  10.2.3 Green Cross Corporation Recombinant Vaccines Product Market Performance
  10.2.4 Green Cross Corporation Business Overview
  10.2.5 Green Cross Corporation SWOT Analysis
  10.2.6 Green Cross Corporation Recent Developments
10.3 Pfizer Inc.
  10.3.1 Pfizer Inc. Basic Information
  10.3.2 Pfizer Inc. Recombinant Vaccines Product Overview
  10.3.3 Pfizer Inc. Recombinant Vaccines Product Market Performance
  10.3.4 Pfizer Inc. Business Overview
  10.3.5 Pfizer Inc. SWOT Analysis
  10.3.6 Pfizer Inc. Recent Developments
10.4 Bayer AG
  10.4.1 Bayer AG Basic Information
  10.4.2 Bayer AG Recombinant Vaccines Product Overview
  10.4.3 Bayer AG Recombinant Vaccines Product Market Performance
  10.4.4 Bayer AG Business Overview
  10.4.5 Bayer AG Recent Developments
10.5 Sanofi S A.
  10.5.1 Sanofi S A. Basic Information
  10.5.2 Sanofi S A. Recombinant Vaccines Product Overview
  10.5.3 Sanofi S A. Recombinant Vaccines Product Market Performance
  10.5.4 Sanofi S A. Business Overview
  10.5.5 Sanofi S A. Recent Developments
10.6 Protein Science Corporation
  10.6.1 Protein Science Corporation Basic Information
  10.6.2 Protein Science Corporation Recombinant Vaccines Product Overview
  10.6.3 Protein Science Corporation Recombinant Vaccines Product Market Performance
  10.6.4 Protein Science Corporation Business Overview
  10.6.5 Protein Science Corporation Recent Developments
10.7 GlaxoSmithKline Plc.
  10.7.1 GlaxoSmithKline Plc. Basic Information
  10.7.2 GlaxoSmithKline Plc. Recombinant Vaccines Product Overview
  10.7.3 GlaxoSmithKline Plc. Recombinant Vaccines Product Market Performance
  10.7.4 GlaxoSmithKline Plc. Business Overview
  10.7.5 GlaxoSmithKline Plc. Recent Developments
10.8 Novartis AG
  10.8.1 Novartis AG Basic Information
  10.8.2 Novartis AG Recombinant Vaccines Product Overview
  10.8.3 Novartis AG Recombinant Vaccines Product Market Performance
  10.8.4 Novartis AG Business Overview
  10.8.5 Novartis AG Recent Developments
10.9 Bharat Biotech
  10.9.1 Bharat Biotech Basic Information
  10.9.2 Bharat Biotech Recombinant Vaccines Product Overview
  10.9.3 Bharat Biotech Recombinant Vaccines Product Market Performance
  10.9.4 Bharat Biotech Business Overview
  10.9.5 Bharat Biotech Recent Developments
10.10 AstraZeneca Plc.
  10.10.1 AstraZeneca Plc. Basic Information
  10.10.2 AstraZeneca Plc. Recombinant Vaccines Product Overview
  10.10.3 AstraZeneca Plc. Recombinant Vaccines Product Market Performance
  10.10.4 AstraZeneca Plc. Business Overview
  10.10.5 AstraZeneca Plc. Recent Developments
10.11 Johnson and Johnson
  10.11.1 Johnson and Johnson Basic Information
  10.11.2 Johnson and Johnson Recombinant Vaccines Product Overview
  10.11.3 Johnson and Johnson Recombinant Vaccines Product Market Performance
  10.11.4 Johnson and Johnson Business Overview
  10.11.5 Johnson and Johnson Recent Developments
10.12 Emergent BioSolutions Inc
  10.12.1 Emergent BioSolutions Inc Basic Information
  10.12.2 Emergent BioSolutions Inc Recombinant Vaccines Product Overview
  10.12.3 Emergent BioSolutions Inc Recombinant Vaccines Product Market Performance
  10.12.4 Emergent BioSolutions Inc Business Overview
  10.12.5 Emergent BioSolutions Inc Recent Developments
10.13 Novavax, Inc
  10.13.1 Novavax, Inc Basic Information
  10.13.2 Novavax, Inc Recombinant Vaccines Product Overview
  10.13.3 Novavax, Inc Recombinant Vaccines Product Market Performance
  10.13.4 Novavax, Inc Business Overview
  10.13.5 Novavax, Inc Recent Developments
10.14 Serum Institute of India Pvt. Ltd
  10.14.1 Serum Institute of India Pvt. Ltd Basic Information
  10.14.2 Serum Institute of India Pvt. Ltd Recombinant Vaccines Product Overview
  10.14.3 Serum Institute of India Pvt. Ltd Recombinant Vaccines Product Market Performance
  10.14.4 Serum Institute of India Pvt. Ltd Business Overview
  10.14.5 Serum Institute of India Pvt. Ltd Recent Developments
10.15 Dynavax Technologies Corporation
  10.15.1 Dynavax Technologies Corporation Basic Information
  10.15.2 Dynavax Technologies Corporation Recombinant Vaccines Product Overview
  10.15.3 Dynavax Technologies Corporation Recombinant Vaccines Product Market Performance
  10.15.4 Dynavax Technologies Corporation Business Overview
  10.15.5 Dynavax Technologies Corporation Recent Developments

11 RECOMBINANT VACCINES MARKET FORECAST BY REGION

11.1 Global Recombinant Vaccines Market Size Forecast
11.2 Global Recombinant Vaccines Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Recombinant Vaccines Market Size Forecast by Country
  11.2.3 Asia Pacific Recombinant Vaccines Market Size Forecast by Region
  11.2.4 South America Recombinant Vaccines Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Recombinant Vaccines by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Recombinant Vaccines Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Recombinant Vaccines by Type (2026-2035)
  12.1.2 Global Recombinant Vaccines Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Recombinant Vaccines by Type (2026-2035)
12.2 Global Recombinant Vaccines Market Forecast by Application (2026-2035)
  12.2.1 Global Recombinant Vaccines Sales (K MT) Forecast by Application
  12.2.2 Global Recombinant Vaccines Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Recombinant Vaccines Market Size by Type (M USD)
Table 4. Global Recombinant Vaccines Market Size by Application
Table 5. Recombinant Vaccines Market Size Comparison by Region (M USD)
Table 6. Global Recombinant Vaccines Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Recombinant Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Recombinant Vaccines Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Recombinant Vaccines Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Vaccines as of 2025)
Table 11. Global Market Recombinant Vaccines Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Recombinant Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Recombinant Vaccines Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Recombinant Vaccines Sales by Type (K MT)
Table 27. Global Recombinant Vaccines Market Size by Type (M USD)
Table 28. Global Recombinant Vaccines Sales (K MT) by Type (2020-2025)
Table 29. Global Recombinant Vaccines Sales Market Share by Type (2020-2025)
Table 30. Global Recombinant Vaccines Market Size (M USD) by Type (2020-2025)
Table 31. Global Recombinant Vaccines Market Share by Type (2020-2025)
Table 32. Global Recombinant Vaccines Price (USD/KG) by Type (2020-2025)
Table 33. Global Recombinant Vaccines Sales (K MT) by Application
Table 34. Global Recombinant Vaccines Market Size by Application
Table 35. Global Recombinant Vaccines Sales by Application (2020-2025) & (K MT)
Table 36. Global Recombinant Vaccines Sales Market Share by Application (2020-2025)
Table 37. Global Recombinant Vaccines Market Size by Application (2020-2025) & (M USD)
Table 38. Global Recombinant Vaccines Market Share by Application (2020-2025)
Table 39. Global Recombinant Vaccines Sales Growth Rate by Application (2020-2025)
Table 40. Global Recombinant Vaccines Sales by Region (2020-2025) & (K MT)
Table 41. Global Recombinant Vaccines Sales Market Share by Region (2020-2025)
Table 42. Global Recombinant Vaccines Market Size by Region (2020-2025) & (M USD)
Table 43. Global Recombinant Vaccines Market Size by Region (2020-2025)
Table 44. North America Recombinant Vaccines Sales by Country (2020-2025) & (K MT)
Table 45. North America Recombinant Vaccines Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Recombinant Vaccines Sales by Country (2020-2025) & (K MT)
Table 47. Europe Recombinant Vaccines Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Recombinant Vaccines Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Recombinant Vaccines Market Size by Region (2020-2025) & (M USD)
Table 50. South America Recombinant Vaccines Sales by Country (2020-2025) & (K MT)
Table 51. South America Recombinant Vaccines Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Recombinant Vaccines Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Recombinant Vaccines Market Size by Region (2020-2025) & (M USD)
Table 54. Global Recombinant Vaccines Production (K MT) by Region(2020-2025)
Table 55. Global Recombinant Vaccines Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Recombinant Vaccines Revenue Market Share by Region (2020-2025)
Table 57. Global Recombinant Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Recombinant Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Recombinant Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Recombinant Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Recombinant Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Merck and Co., Inc Basic Information
Table 63. Merck and Co., Inc Recombinant Vaccines Product Overview
Table 64. Merck and Co., Inc Recombinant Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Merck and Co., Inc Business Overview
Table 66. Merck and Co., Inc SWOT Analysis
Table 67. Merck and Co., Inc Recent Developments
Table 68. Green Cross Corporation Basic Information
Table 69. Green Cross Corporation Recombinant Vaccines Product Overview
Table 70. Green Cross Corporation Recombinant Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Green Cross Corporation Business Overview
Table 72. Green Cross Corporation SWOT Analysis
Table 73. Green Cross Corporation Recent Developments
Table 74. Pfizer Inc. Basic Information
Table 75. Pfizer Inc. Recombinant Vaccines Product Overview
Table 76. Pfizer Inc. Recombinant Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Pfizer Inc. Business Overview
Table 78. Pfizer Inc. SWOT Analysis
Table 79. Pfizer Inc. Recent Developments
Table 80. Bayer AG Basic Information
Table 81. Bayer AG Recombinant Vaccines Product Overview
Table 82. Bayer AG Recombinant Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Bayer AG Business Overview
Table 84. Bayer AG Recent Developments
Table 85. Sanofi S A. Basic Information
Table 86. Sanofi S A. Recombinant Vaccines Product Overview
Table 87. Sanofi S A. Recombinant Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Sanofi S A. Business Overview
Table 89. Sanofi S A. Recent Developments
Table 90. Protein Science Corporation Basic Information
Table 91. Protein Science Corporation Recombinant Vaccines Product Overview
Table 92. Protein Science Corporation Recombinant Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Protein Science Corporation Business Overview
Table 94. Protein Science Corporation Recent Developments
Table 95. GlaxoSmithKline Plc. Basic Information
Table 96. GlaxoSmithKline Plc. Recombinant Vaccines Product Overview
Table 97. GlaxoSmithKline Plc. Recombinant Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. GlaxoSmithKline Plc. Business Overview
Table 99. GlaxoSmithKline Plc. Recent Developments
Table 100. Novartis AG Basic Information
Table 101. Novartis AG Recombinant Vaccines Product Overview
Table 102. Novartis AG Recombinant Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Novartis AG Business Overview
Table 104. Novartis AG Recent Developments
Table 105. Bharat Biotech Basic Information
Table 106. Bharat Biotech Recombinant Vaccines Product Overview
Table 107. Bharat Biotech Recombinant Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Bharat Biotech Business Overview
Table 109. Bharat Biotech Recent Developments
Table 110. AstraZeneca Plc. Basic Information
Table 111. AstraZeneca Plc. Recombinant Vaccines Product Overview
Table 112. AstraZeneca Plc. Recombinant Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. AstraZeneca Plc. Business Overview
Table 114. AstraZeneca Plc. Recent Developments
Table 115. Johnson and Johnson Basic Information
Table 116. Johnson and Johnson Recombinant Vaccines Product Overview
Table 117. Johnson and Johnson Recombinant Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Johnson and Johnson Business Overview
Table 119. Johnson and Johnson Recent Developments
Table 120. Emergent BioSolutions Inc Basic Information
Table 121. Emergent BioSolutions Inc Recombinant Vaccines Product Overview
Table 122. Emergent BioSolutions Inc Recombinant Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Emergent BioSolutions Inc Business Overview
Table 124. Emergent BioSolutions Inc Recent Developments
Table 125. Novavax, Inc Basic Information
Table 126. Novavax, Inc Recombinant Vaccines Product Overview
Table 127. Novavax, Inc Recombinant Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Novavax, Inc Business Overview
Table 129. Novavax, Inc Recent Developments
Table 130. Serum Institute of India Pvt. Ltd Basic Information
Table 131. Serum Institute of India Pvt. Ltd Recombinant Vaccines Product Overview
Table 132. Serum Institute of India Pvt. Ltd Recombinant Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Serum Institute of India Pvt. Ltd Business Overview
Table 134. Serum Institute of India Pvt. Ltd Recent Developments
Table 135. Dynavax Technologies Corporation Basic Information
Table 136. Dynavax Technologies Corporation Recombinant Vaccines Product Overview
Table 137. Dynavax Technologies Corporation Recombinant Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Dynavax Technologies Corporation Business Overview
Table 139. Dynavax Technologies Corporation Recent Developments
Table 140. Global Recombinant Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 141. Global Recombinant Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 142. North America Recombinant Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 143. North America Recombinant Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 144. Europe Recombinant Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 145. Europe Recombinant Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Asia Pacific Recombinant Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 147. Asia Pacific Recombinant Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America Recombinant Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 149. South America Recombinant Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Middle East and Africa Recombinant Vaccines Sales Forecast by Country (2026-2035) & (Units)
Table 151. Middle East and Africa Recombinant Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Global Recombinant Vaccines Sales Forecast by Type (2026-2035) & (K MT)
Table 153. Global Recombinant Vaccines Market Size Forecast by Type (2026-2035) & (M USD)
Table 154. Global Recombinant Vaccines Price Forecast by Type (2026-2035) & (USD/KG)
Table 155. Global Recombinant Vaccines Sales (K MT) Forecast by Application (2026-2035)
Table 156. Global Recombinant Vaccines Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Recombinant Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Recombinant Vaccines Market Size (M USD), 2025-2035
Figure 5. Global Recombinant Vaccines Market Size (M USD) (2020-2035)
Figure 6. Global Recombinant Vaccines Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Recombinant Vaccines Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Recombinant Vaccines Product Life Cycle
Figure 13. Recombinant Vaccines Sales Share by Manufacturers in 2025
Figure 14. Global Recombinant Vaccines Revenue Share by Manufacturers in 2025
Figure 15. Recombinant Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Recombinant Vaccines Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Recombinant Vaccines Revenue in 2025
Figure 18. Industry Chain Map of Recombinant Vaccines
Figure 19. Global Recombinant Vaccines Market PEST Analysis
Figure 20. Global Recombinant Vaccines Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Recombinant Vaccines Market Share by Type
Figure 27. Sales Market Share of Recombinant Vaccines by Type (2020-2025)
Figure 28. Sales Market Share of Recombinant Vaccines by Type in 2025
Figure 29. Market Share of Recombinant Vaccines by Type (2020-2025)
Figure 30. Market Share of Recombinant Vaccines by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Recombinant Vaccines Market Share by Application
Figure 33. Global Recombinant Vaccines Sales Market Share by Application (2020-2025)
Figure 34. Global Recombinant Vaccines Sales Market Share by Application in 2025
Figure 35. Global Recombinant Vaccines Market Share by Application (2020-2025)
Figure 36. Global Recombinant Vaccines Market Share by Application in 2025
Figure 37. Global Recombinant Vaccines Sales Growth Rate by Application (2020-2025)
Figure 38. Global Recombinant Vaccines Sales Market Share by Region (2020-2025)
Figure 39. Global Recombinant Vaccines Market Size by Region (2020-2025)
Figure 40. North America Recombinant Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Recombinant Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Recombinant Vaccines Sales Market Share by Country in 2024
Figure 43. North America Recombinant Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Recombinant Vaccines Market Size by Country in 2024
Figure 45. U.S. Recombinant Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Recombinant Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Recombinant Vaccines Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Recombinant Vaccines Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Recombinant Vaccines Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Recombinant Vaccines Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Recombinant Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Recombinant Vaccines Sales Market Share by Country in 2024
Figure 53. Europe Recombinant Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Recombinant Vaccines Market Size by Country in 2024
Figure 55. Germany Recombinant Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Recombinant Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Recombinant Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Recombinant Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Recombinant Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Recombinant Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Recombinant Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Recombinant Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Recombinant Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Recombinant Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Recombinant Vaccines Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Recombinant Vaccines Sales Market Share by Region in 2024
Figure 67. Asia Pacific Recombinant Vaccines Market Size by Region in 2024
Figure 68. China Recombinant Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Recombinant Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Recombinant Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Recombinant Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Recombinant Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Recombinant Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Recombinant Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Recombinant Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Recombinant Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Recombinant Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Recombinant Vaccines Sales and Growth Rate (K MT)
Figure 79. South America Recombinant Vaccines Sales Market Share by Country in 2024
Figure 80. South America Recombinant Vaccines Market Size and Growth Rate (M USD)
Figure 81. South America Recombinant Vaccines Market Size by Country in 2024
Figure 82. Brazil Recombinant Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Recombinant Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Recombinant Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Recombinant Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Recombinant Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Recombinant Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Recombinant Vaccines Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Recombinant Vaccines Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Recombinant Vaccines Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Recombinant Vaccines Market Size by Region in 2024
Figure 92. Saudi Arabia Recombinant Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Recombinant Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Recombinant Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Recombinant Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Recombinant Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Recombinant Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Recombinant Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Recombinant Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Recombinant Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Recombinant Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Recombinant Vaccines Production Market Share by Region (2020-2025)
Figure 103. North America Recombinant Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Recombinant Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Recombinant Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 106. China Recombinant Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Recombinant Vaccines Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Recombinant Vaccines Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Recombinant Vaccines Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Recombinant Vaccines Market Share Forecast by Type (2026-2035)
Figure 111. Global Recombinant Vaccines Sales Forecast by Application (2026-2035)
Figure 112. Global Recombinant Vaccines Market Share Forecast by Application (2026-2035)